About Outcomes'10
Outcomes'10 is a Healthcare company based in Spain founded in 2009, and was acquired by ProductLife Group in September 2024. Its focus areas include Traditional Nutraceuticals, Dietary Supplements and Vitamins & Minerals.
Company details
Provider of health research, economic, and market access services. This company designs and develops innovative research projects, combining scientific methodology with strategic vision. Services encompass the entire project lifecycle, from conception to results dissemination, including supplementary offerings such as meeting management, graphic design, e-health solutions, and translation services. They support various therapeutic areas and contribute to scientific knowledge advancement and improved patient quality of life through publications, articles, books, congress participation, doctoral theses, training, and podcasts.
- Headquarters Spain
- Stage Acquired
- SectorsHealthcare
- Website outcomes10.com
- Social X
- Acquired by ProductLife Group (Sep 2024)
- Latest Funding Round$142.77K (USD), Grant
Apr 2021
- InvestorsProductLife Group
& 1 more
- Acquired byProductLife Group
(Sep 2024)
Funding Insights of Outcomes'10
- Total Rounds 1
- Last Round Grant β $142,766
- First Round $142,766
(Apr 2021)
- Investors Count 1
All 1 funding rounds of Outcomes10 with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2021 | $142,766 | Grant | β | β |
2 investors in total: 2 institutional.
Investors in Outcomes'10
Outcomes'10 has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include ProductLife Group and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Regulatory and pharmacovigilance support is provided for product lifecycles. | 2000 | productlifegroup.com | Suresnes, France |
Investor details for Outcomes10
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Outcomes'10
3 dated milestones of Outcomes'10 across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Outcomes'10 is founded.
- Funding First funding round of $143K.
- Exit Acquired by ProductLife Group.
Web traffic of Outcomes'10
The website of Outcomes'10 (outcomes10.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 5.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Outcomes'10
Outcomes'10 was founded in 2009 and raised its 1st funding round 12 years after it was founded.
Outcomes'10 is headquartered in Spain.
Provider of health research, economic, and market access services. This company designs and develops innovative research projects, combining scientific methodology with strategic vision. Services encompass the entire project lifecycle, from conception to results dissemination, including supplementary offerings such as meeting management, graphic design, e-health solutions, and translation services. They support various therapeutic areas and contribute to scientific knowledge advancement and improved patient quality of life through publications, articles, books, congress participation, doctoral theses, training, and podcasts.
Outcomes'10 has 2 investors. Key investors include ProductLife Group, and European Union.
Yes. Outcomes'10 was acquired by ProductLife Group in September 2024.
